Breast Cancer Clinical Trials

Breast cancer clinical trials are crucial to the discovery of treatment methods for the disease and to calculate possible risks. The role of clinical studies and trials is vital, not only for breast cancer, but also for many different types of cancer and other diseases.

Breast cancer clinical trials implement additional treatment methods or drugs to measure their effect on the disease along with the side effects. Clinical research processes, consisting of different stages, observe treatment methods or drugs at various stages of the cancer.

What Are Breast Cancer Clinical Trials?

Breast cancer clinical trials are processes where doctors test new treatment methods, observe side effects, and produce solutions in line with these observations. In the last 40 years, clinical trials have had a great impact on the development of breast cancer treatment processes. Clinical research basically consists of the following 4 stages.

• Phase 1: The phase where the safety of the drug to be used is examined.
• Phase 2: The phase where the drug produced is examined to determine effectiveness, especially in a certain type of cancer.
• Phase 3: The phase where the pros and cons of the new treatment are compared to the standard treatment.
• Phase 4: The phase in which the long-term effects of the new treatment are monitored. This stage begins after the treatment is approved by the authorized institutions.

Who Can Participate in Clinical Trials?

Clinical research processes have their own specific conditions. The reason is to achieve more reliable and effective results. For each procedure, groups suitable with certain specific characteristics are selected.

In addition to the reliability of the research, the health status of the patient, to whom the treatment will be applied, is also taken into consideration. Other pre-existing health problems of the patient are also evaluated before the trial.

Average Duration of Clinical Trials

Clinical trials are processes that span many years and have many different criteria. The safety of the treatment found needs to be observed both in the short and long term. In general, monitoring for at least 5 to 10 years is required to observe and recognize long-term results and effects. This may differ depending on the treatment.